Search  -  prev / next

Biotechnology

CMG Canadian Marketing Group, an Ottawa-based technology, marketing and management consulting firm, has released three exciting Canadian Technology Reports * in the life sciences area. All three reports are unique in that this is the first time information has been collected in these areas and analyzed in Canada.

These first three reports in the Canadian Technology Report series are:
Cancer R&D in Canada '96
Gene Therapy R&D in Canada '96
Monoclonal Antibody R&D in Canada '96

Each report provides an in-depth review of the Canadian research and development pipeline, including activities carried out at the universities, government research laboratories, hospital research institutes and companies.

These reports were designed for decision-makers involved in research and development; senior executives of research organizations, biotechnology and pharmaceutical companies, venture capital firms, funding agencies and government agencies.

The above reports are available for purchase from CMG. For further information on these reports, or CMG's consulting services, please call Peter Kallai at (613) 567-9406.

CMG is an Ottawa based technology, marketing and management consulting company with both Canadian and international experience in the life sciences and the biotechnology sectors. Since its inception in 1990, CMG has delivered over 50 major consulting projects. With its business and Ph.D. technology consultants, CMG is uniquely positioned to serve a wide variety organizations and needs.

Headings

Cancer R&D, Gene Therapy R&D, Monoclonal Antibody R&D, Canada '96

Generated by documents 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability and Copyright.